Aerosolized CBD Liposomes for the treatment of Asthma and other pulmonary inflammatory disorders

摘要

The present disclosure relates to the new compounds and improved treatment regimens that are effective in treating patients and minimizing the negative side effects previously associated with pulmonary care and treatment. Specifically, liposomal cannabinoids with or without other known treatments are used to provide a more effective and safer treatment for Asthma and/or pulmonary inflammation disorders or conditions in a diverse population.